Biosynex SA (EPA: ALBIO)
France
· Delayed Price · Currency is EUR 2.880
+0.060 (2.13%)
Nov 21, 2024, 5:35 PM CET
Biosynex Revenue
Biosynex had revenue of 53.74M EUR in the half year ending June 30, 2024, a decrease of -62.22%. This brings the company's revenue in the last twelve months to 104.07M, up 7.29% year-over-year. In the year 2023, Biosynex had annual revenue of 92.98M, down -52.70%.
Revenue (ttm)
104.07M
Revenue Growth
+7.29%
P/S Ratio
0.30
Revenue / Employee
202.07K
Employees
569
Market Cap
30.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 92.98M | -103.61M | -52.70% |
| Dec 31, 2022 | 196.59M | -185.95M | -48.61% |
| Dec 31, 2021 | 382.53M | 228.64M | 148.57% |
| Dec 31, 2020 | 153.90M | 118.72M | 337.54% |
| Dec 31, 2019 | 35.17M | 3.87M | 12.38% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Ipsen S.A. | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |